Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægerne Børsting og Ejstrup ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   1.3% 1.2% 0.8% 1.4% 0.9% 0.8% 7.1% 6.8%   Credit score (0-100)   82 84 90 77 88 90 34 35   Credit rating   A A A A A AA BBB BBB   Credit limit (kDKK)   21.7 58.3 172.6 24.7 248.6 307.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,694 3,664 3,817 4,354 4,829 4,568 0.0 0.0   EBITDA   355 753 619 2,370 1,459 1,198 0.0 0.0   EBIT   289 685 548 2,292 1,368 1,092 0.0 0.0   Pre-tax profit (PTP)   270.6 661.4 533.8 2,264.4 1,320.3 1,058.4 0.0 0.0   Net earnings   210.1 513.4 414.7 1,764.8 1,027.7 846.4 0.0 0.0   Pre-tax profit without non-rec. items   271 661 534 2,264 1,320 1,058 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   108 95.7 92.2 49.4 257 253 0.0 0.0   Shareholders equity total   489 702 817 882 1,510 1,656 806 806   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,349 1,762 1,757 2,433 2,429 2,317 806 806   Net Debt   -282 -713 -718 -1,421 -1,337 -1,195 -342 -342     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,694 3,664 3,817 4,354 4,829 4,568 0.0 0.0   Gross profit growth   0.0% -0.8% 4.2% 14.1% 10.9% -5.4% -100.0% 0.0%   Employees   6 6 6 7 8 8 0 0   Employee growth %   0.0% 0.0% 0.0% 16.7% 14.3% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,349 1,762 1,757 2,433 2,429 2,317 806 806   Balance sheet change%   0.0% 30.6% -0.3% 38.4% -0.2% -4.6% -65.2% 0.0%   Added value   354.8 752.9 619.2 2,370.1 1,446.1 1,197.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   681 -115 -109 -155 81 -144 -253 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   7.8% 18.7% 14.4% 52.6% 28.3% 23.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   21.6% 44.2% 31.2% 109.5% 56.3% 46.2% 0.0% 0.0%   ROI %   55.9% 108.1% 67.5% 250.8% 107.3% 65.3% 0.0% 0.0%   ROE %   43.0% 86.2% 54.6% 207.8% 85.9% 53.5% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   36.3% 37.2% 46.5% 36.3% 62.2% 71.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -79.5% -94.7% -116.0% -60.0% -91.6% -99.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.6 0.9 1.1 1.2 1.9 2.7 0.0 0.0   Current Ratio   0.6 1.0 1.2 1.2 1.9 2.7 0.0 0.0   Cash and cash equivalent   281.9 713.3 718.2 1,421.2 1,337.0 1,194.6 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -304.3 -30.4 135.7 288.0 757.5 958.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   59 125 103 339 181 150 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   59 125 103 339 182 150 0 0   EBIT / employee   48 114 91 327 171 137 0 0   Net earnings / employee   35 86 69 252 128 106 0 0